← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Central Garden & Pet improved margins and cash flow through lower revenue, but weaker operating-cash conversion showed continued demand pressure.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 2.2%Watch
- Profitability — Net income grew 50.8% to $162.843M from $107.983MOK
- Cash flow — Free cash flow declined 17.2% to $291.088M from $351.757MWatch
- Margins — Operating margin expanded 220 bps to 7.99%OK
- Accounting — Margin defense through softer demandNote
- Insiders — 0 purchases and 9 salesNote
Business
Central Garden & Pet produces and distributes pet and garden products.
Where the revenue comes from
Fiscal 2025, as CENTRAL GARDEN & PET CO reports it. History and quarterly detail are in the app.
- Pet Products$1.8B
- Garden Products$1.3B
Leadership changes
From CENTRAL GARDEN & PET CO's own filings, the day they're filed.
- Kay M. Schwichtenberg · President · departureeff. 2026-03-01
- Randal D. Lewis · Directors · appointmenteff. 2024-12-11
- Nicholas Lahanas · Chief Executive Officer · appointmenteff. 2024-09-29
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-07-27
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CENTRAL GARDEN & PET CO, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.